Drug
AR 301
AR 301: highest development phase Phase 3, developed by Aridis Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Aridis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| AR-301 NCT03816956 | Phase 3 | Lung Infection |
Latest
No recent events.
Follow AR 301 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.